Published in Dtsch Med Wochenschr on April 18, 1969
Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci U S A (1995) 4.89
Centrally mediated decrease in sympathetic tone induced by 2(2,6-dichlorophenylamino)-2 imidazoline (S.T. 155, Catapresan). Eur J Pharmacol (1967) 2.73
E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res (1991) 2.67
Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation. Breast Cancer Res Treat (2001) 2.26
Evidence for an alpha-sympathomimetic component in the effects of catapresan on vasomotor centres: antagonism by piperoxane. Eur J Pharmacol (1971) 2.15
Ca2+ triggers massive exocytosis in Chinese hamster ovary cells. EMBO J (1996) 1.80
Action of -adrenergic blocking drugs on the sympathetic centres and their interactions with the central sympatho-inhibitory effect of clonidine. Arzneimittelforschung (1973) 1.71
A universal spine tester for in vitro experiments with muscle force simulation. Eur Spine J (1994) 1.65
Expression of the gap-junction connexins 26 and 30 in the rat cochlea. Cell Tissue Res (1998) 1.58
Simultaneous determination of neuromuscular block at the larynx, diaphragm, adductor pollicis, orbicularis oculi and corrugator supercilii muscles. Br J Anaesth (2000) 1.58
Cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155). II. Central sympathetic structures. Eur J Pharmacol (1968) 1.56
[Pharmacologic study of fenfluramine and its optical isomers]. Arch Int Pharmacodyn Ther (1966) 1.55
The fine structure of freeze-fractured intercellular junctions in the guinea pig inner ear. Acta Otolaryngol Suppl (1975) 1.51
Contig assembly of bacterial artificial chromosome clones through multiplexed fluorescence-labeled fingerprinting. Genomics (1999) 1.48
Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group Report. Ann Oncol (2007) 1.47
Retroperitoneal lymphangiectasia associated with bilateral renal vein thrombosis. Nephrol Dial Transplant (1997) 1.45
Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group Report. Neurology (2008) 1.44
[Ambulatory rehabilitation after cochlear prosthesis implantation]. HNO (2000) 1.40
[Osteosynthesis in facial bones: silicon nitride ceramic as material]. HNO (2006) 1.39
A technique for recording sympathetic nerve activity in unanaesthetized dogs. Neuropharmacology (1974) 1.38
[Reconstruction of the superstructure of the stapes in guinea pigs with biovitro ceramic and silicone foil]. HNO (2002) 1.38
Health care expenditure in the last months of life. J Health Econ (2000) 1.35
Translation in vitro of rat brain messenger RNA coding for tubulin and actin. Proc Natl Acad Sci U S A (1975) 1.31
Sedative effects of alpha-sympathomimetic drugs and their antagonism by adrenergic and cholinergic blocking drugs. Eur J Pharmacol (1971) 1.26
Studies on dl-4-(2-hydroxy-3-isopropylaminopropoxy)-indole A/Giudicelli JF, Schmitt H, Boissier JR: Studies on dl-4-(2-hydroxy-3-isopropylaminopropoxy)-indole (LB 46), a new potent beta adrenergic blocking drug. J Pharmacol Exp Ther (1969) 1.22
Molecular definition of a novel human galectin which is immunogenic in patients with Hodgkin's disease. J Biol Chem (1997) 1.21
Activation of transcription factor AP-2 mediates UVA radiation- and singlet oxygen-induced expression of the human intercellular adhesion molecule 1 gene. Proc Natl Acad Sci U S A (1996) 1.19
Prospective trial on topotecan salvage therapy in primary CNS lymphoma. Ann Oncol (2006) 1.17
Demonstration of identical clonal derivation in a case of "oculocerebral" lymphoma. Br J Ophthalmol (2005) 1.16
Central cardiovascular effects of morphinomimetic peptides in dogs. Eur J Pharmacol (1977) 1.16
The long-term prognosis of the primary glomerulonephritides. A morphological and clinical analysis of 1747 cases. Pathol Res Pract (1992) 1.15
Antinociceptive effects of some alpha-sympathomimetic agents. Neuropharmacology (1974) 1.13
Mutations in the connexin26/GJB2 gene are the most common event in non-syndromic hearing loss among the German population. Hum Mutat (2001) 1.12
Photoinactivation of viruses in human fresh plasma by phenothiazine dyes in combination with visible light. Vox Sang (1991) 1.11
Measurement of spin-transfer observables in p p-->Lambda Lambda at 1.637 GeV/c. Phys Rev Lett (2002) 1.09
Developmental expression patterns of connexin26 and -30 in the rat cochlea. Dev Genet (1999) 1.09
Inhibition of angiotensin I-converting enzyme with S 9490: biochemical effects, interspecies differences, and role of sodium diet in hemodynamic effects. J Cardiovasc Pharmacol (1985) 1.08
The consequences of tubulo-interstitial changes for renal function in glomerulopathies. A morphometric and cytological analysis. Pathol Res Pract (1990) 1.06
Reduced frequency of severe hypoglycemia and coma in well-controlled IDDM patients treated with insulin lispro. The Benelux-UK Insulin Lispro Study Group. Diabetes Care (1997) 1.05
Cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155). I. Peripheral sympathetic system. Eur J Pharmacol (1968) 1.03
Decrease in levels and rates of synthesis of tubulin and actin in developing rat brain. Brain Res (1977) 1.01
Ventrolateral medullary pressor area: site of hypotensive and sympatho-inhibitory effects of (+/-)8-OH-DPAT in anaesthetized dogs. Eur J Pharmacol (1989) 1.01
Analysis of injuries in long-distance triathletes. Int J Sports Med (2003) 1.00
Localization of the hypotenisve effect of 2-(2-6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155, Catapresan). Eur J Pharmacol (1969) 0.99
A further attempt to characterize sedative receptors activated by clonidine in chickens and mice. Eur J Pharmacol (1973) 0.99
[Actions of diazoxide on the cardiovascular system, on the metabolism of the myocardium and on sympathetic discharges]. Arch Int Pharmacodyn Ther (1968) 0.98
Effect of clonidine on sleep patterns in man. Eur J Clin Pharmacol (1977) 0.98
Pharmacological properties of (N-dicyclopropylmethyl) amino-2-oxazoline (S 3341), an alpha-2 adrenoceptor agonist. J Pharmacol (1986) 0.97
[Lymphatic metastases of verrucous carcinoma (Ackerman tumor)]. HNO (1987) 0.97
[Intercellular junctions in the guinea pig stria vascularis as shown by freeze-etching (author's transl)]. Anat Embryol (Berl) (1975) 0.97
Centrally mediated bradycardia and hypotension induced by narcotic analgesics: dextromoramide and fentanyl. Eur J Pharmacol (1974) 0.97
Toxic epidermal necrolysis in patients receiving glucocorticosteroids. Acta Derm Venereol (1991) 0.97
[Prosthetic supply of tissue defects in head and neck surgery]. Laryngorhinootologie (2007) 0.96
PYD2 encodes 5,6-dihydropyrimidine amidohydrolase, which participates in a novel fungal catabolic pathway. J Mol Biol (2000) 0.96
International validation of a health-related quality of life questionnaire in patients with erosive gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2008) 0.96
Long-lasting hyperventilation induced by almitrine: evidence for a specific effect on carotid and thoracic chemoreceptors. Eur J Pharmacol (1980) 0.95
Pharmacological evidence for a central alpha-sympathomimetic mechanism controlling blood pressure and heart rate. Circ Res (1976) 0.94
Unsatisfactory specificities and sensitivities of six enzyme immunoassays for antibodies to hepatitis B core antigen. J Clin Microbiol (1989) 0.94
Pre- and postsynaptic a-adrenoceptor blockade by (imidazolinyl-2)-2-benzodioxane 1-4 (170 150): antagonistic action on the central effects of clonidine. Arch Int Pharmacodyn Ther (1981) 0.93
Sports injuries: population based representative data on incidence, diagnosis, sequelae, and high risk groups. Br J Sports Med (2006) 0.93
Indication for central vagal endorphinergic control of heart rate in dogs. Eur J Pharmacol (1981) 0.92
[Fine structural studies on the permeability barriers of the inner ear (author's transl)]. Arch Klin Exp Ohren Nasen Kehlkopfheilkd (1973) 0.92
Renal artery stenosis: evaluation with colour duplex ultrasonography. Nephrol Dial Transplant (1997) 0.91
Comparative investigation of the biocompatibility of various silicon nitride ceramic qualities in vitro. J Mater Sci Mater Med (2004) 0.90
Cyclic 3'5'-adenosine monophosphate and central circulatory control in cats and dogs. Clin Exp Pharmacol Physiol (1977) 0.90
Interactions between the autonomic nervous system and the cardiovascular effects of ouabain in guinea-pigs. Eur J Pharmacol (1982) 0.90
Interactions between 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155, Catapresan) and alpha-adrenergic blocking drugs. Eur J Pharmacol (1970) 0.90
Vascular variations of the inner ear. Acta Otolaryngol (2001) 0.90
Induction chemotherapy followed by concurrent chemotherapy and high-dose radiotherapy for locally advanced squamous cell carcinoma of the cervical oesophagus. Oncology (1999) 0.90
[Prevalence and correlates of osteoarthritis in Germany. Representative data from the First National Health Survey]. Orthopade (2005) 0.89
Pharmacokinetics of gentamicin after i.v. infusion or iv bolus. J Antimicrob Chemother (1987) 0.89
Specific affinity labelling of tubulin with bromocolchicine. J Mol Biol (1976) 0.89
New evidence for an -andrenergic component in the sympathetic centres: centrally mediated decrease in sympathetic tone by L-dopa and its antagonism by piperoxane and yohimbine. Eur J Pharmacol (1972) 0.88
Hypothermic effect of alpha-sympathomimetic agents and their antagonism by adrenergic and cholinergic blocking drugs. Neuropharmacology (1972) 0.88
Image registration and analysis for quantitative myocardial perfusion: application to dynamic circular cardiac CT. Phys Med Biol (2011) 0.88
[EEG changes in diabetic children]. Dtsch Med Wochenschr (1973) 0.87
The blood-perilymph barrier. Arch Otorhinolaryngol (1980) 0.87
Human trefoil peptides: genomic structure in 21q22.3 and coordinated expression. Eur J Hum Genet (1996) 0.87
Central and peripheral effects of 2-(2,6-dimethylphenylamino)-4-H-5,6-dihydro-1,3-thiazin (Bayer 1470) on the sympathetic system. Eur J Pharmacol (1970) 0.86
Percutaneous renal biopsy: comparison of manual and automated puncture techniques with native and transplanted kidneys. Nephrol Dial Transplant (1994) 0.86
New mechanism of antiarrhythmic drug action: increasing L-type calcium current prevents reentrant ventricular tachycardia in the infarcted canine heart. Circulation (2000) 0.86
Characterization of a 72 S mitochondrial ribosome from Saccharomyces cerevisiae. Eur J Biochem (1970) 0.86
Incidence and course of icteric and anicteric transfusion hepatitis. Ger Med Mon (1966) 0.86
Quipazine-induced hypertension in anaesthetized cats is mediated by central and peripheral 5-HT2 receptors: role of the ventrolateral pressor area. Eur J Pharmacol (1991) 0.86
A cell strain system for small homogeneous strain applications. Biomed Tech (Berl) (1997) 0.86
Dopamine receptors in the femoral vascular bed of the dog as mediators of a vasodilator and sympathoinhibitory effect. Eur J Pharmacol (1977) 0.86
Destruction of the nucleus tractus solitarii in the dog: comparison with sinoaortic denervation. Am J Physiol (1979) 0.86
[Effect of sympathomimetics on the vasomotor centers]. Arch Int Pharmacodyn Ther (1971) 0.85
[Familial malignant melanoma and atypical disseminated moles (BK-mole syndrome)]. Hautarzt (1980) 0.85
[Changes in the hypertensive effects of angiotensin by adrenergic and anti-adrenergic agents]. Arch Int Pharmacodyn Ther (1968) 0.85
Effects of some alpha-adrenoceptor agonists and antagonists on the guinea-pig ileum. Naunyn Schmiedebergs Arch Pharmacol (1980) 0.85
Vagal bradycardia produced by microinjections of morphine-like drugs into the nucleus ambiguus in anaesthetized dogs. Eur J Pharmacol (1979) 0.85
The permeability of blood vessels in the guinea pig cochlea. I. Vessels of the modiolus and spiral vessel. Anat Embryol (Berl) (1974) 0.85
Dynamic changes in electrogram morphology at functional lines of block in reentrant circuits during ventricular tachycardia in the infarcted canine heart: a new method to localize reentrant circuits from electrogram features using adaptive template matching. J Cardiovasc Electrophysiol (1999) 0.85